Neurocrine Biosciences Inc (NBIX)
117.44
-5.44
(-4.42%)
USD |
NASDAQ |
Nov 15, 16:00
117.22
-0.22
(-0.19%)
After-Hours: 20:00
Neurocrine Biosciences Gross Profit (Annual): 1.847B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.847B |
| December 31, 2022 | 1.466B |
| December 31, 2021 | 1.119B |
| December 31, 2020 | 1.036B |
| December 31, 2019 | 780.70M |
| December 31, 2018 | 446.30M |
| December 31, 2017 | 160.37M |
| December 31, 2016 | 15.00M |
| December 31, 2015 | 19.77M |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 |
| Date | Value |
|---|---|
| December 31, 2009 | 2.953M |
| December 31, 2008 | 3.975M |
| December 31, 2007 | |
| December 31, 2006 | |
| December 31, 2005 | |
| December 31, 2004 | |
| December 31, 2003 | |
| December 31, 2002 | |
| December 31, 2001 | |
| December 31, 2000 | 16.79M |
| December 31, 1999 | 18.90M |
| December 31, 1998 | 17.70M |
| December 31, 1997 | 27.40M |
| December 31, 1996 | 20.20M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
780.70M
Minimum
2019
1.847B
Maximum
2023
1.250B
Average
1.119B
Median
2021
Gross Profit (Annual) Benchmarks
| Repligen Corp | 284.84M |
| West Pharmaceutical Services Inc | 1.129B |
| Bruker Corp | 1.513B |
| The Cooper Companies Inc | 2.358B |
| Integra Lifesciences Holdings Corp | 884.74M |